Stock Split History
ETFs Holding PRTA »    PRTA Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Prothena is a clinical-stage neuroscience company. Co. is developing a pipeline of therapeutic candidates for a number of indications and targets. Co.'s partnered programs include prasinezumab (PRX002/RG7935) for the potential treatment of Parkinson's disease and other related synucleinopathies, and programs that target tau, TDP-43 and an undisclosed target for the potential treatment of Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia or other neurodegenerative diseases. Co.'s proprietary programs include PRX004 for the potential treatment of ATTR amyloidosis, and programs that target Amyloid beta for the potential treatment of Alzheimer's disease. According to our Prothena stock split history records, Prothena has had 0 splits.
Prothena stock split history picture
Prothena (PRTA) has 0 splits in our Prothena stock split history database.

Looking at the Prothena stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Prothena shares, starting with a $10,000 purchase of PRTA, presented on a split-history-adjusted basis factoring in the complete Prothena stock split history. Prothena split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/24/2012
End date: 09/23/2022
Start price/share: $6.80
End price/share: $30.74
Dividends collected/share: $0.00
Total return: 352.06%
Average Annual Total Return: 16.73%
Starting investment: $10,000.00
Ending investment: $45,193.42
Years: 9.75
Date Ratio
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Prothena

Prothena Stock Split History | | Copyright © 2013 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.